Keratosis pilaris

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Treatments and drugs

By Mayo Clinic staff

No single treatment universally improves keratosis pilaris. Most options, including self-care measures and medicated creams, focus on softening the keratin deposits in the skin.

Treatment of keratosis pilaris can include the following medications:

  • Topical exfoliants. Medicated creams containing alpha-hydroxy, lactic or salicylic acid or urea moisturize and soften dry skin while helping to loosen and remove dead skin cells. Depending on their strength, certain creams are available over-the-counter and others require a prescription. Your doctor can advise you on the best option for your skin. The acids in these creams may cause redness, stinging or skin irritation, and therefore they aren't recommended for young children.
  • Topical corticosteroids. These anti-inflammatory drugs help decrease cell turnover by suppressing the immune system. Low-potency corticosteroid ointments, such as hydrocortisone or derivatives, are usually recommended for sensitive areas such as your face and for treating widespread patches. Doctors usually prescribe corticosteroids for short-term treatment or for temporary relief of symptoms. They aren't used as long-term treatment due to potential side effects from absorbing stronger corticosteroid creams or thinning of the skin. Topical corticosteroids may also cause local burning, itching or irritation.
  • Topical retinoids. Derived from vitamin A, retinoids work by promoting cell turnover and preventing the plugging of the hair follicle. Retinoids may be an effective treatment, but they can cause bothersome skin irritations, such as severe dryness, redness and peeling. Tretinoin (Retin-A Micro, Avita) and tazarotene (Tazorac) are examples of topical retinoids.

Using a medication regularly may improve the appearance of your skin. But if you stop, the condition returns. And even with medical treatment, keratosis pilaris tends to persist for years.

References
  1. Keratosis pilaris. American Osteopathic College of Dermatology. http://www.aocd.org/skin/dermatologic_diseases/keratosis_pilaris.html. Accessed April 22, 2010.
  2. Keratosis pilaris. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec10/ch113/ch113d.html. Accessed April 22, 2010.
  3. Hwang S, et al. Keratosis pilaris: A common follicular hyperkeratosis. Pediatric Dermatology. 2008;82:177.
  4. Rogers M. Keratosis pilaris and other inflammatory follicular keratotic syndromes: Introduction. In: Wolff K, et al. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, N.Y.: The McGraw-Hill Companies; 2008. http://www.accessmedicine.com/content.aspx?aid=2960068. Accessed April 23, 2010.
  5. Dry skin and keratosis pilaris. American Academy of Dermatology. http://www.aad.org/public/publications/pamphlets/skin_dry.html. Accessed April 22, 2010.
  6. Goldstein BG, et al. Approach to the patient with pustular skin lesions. http://www.uptodate.com/home/index.html. Accessed April 22, 2010.
  7. Gibson LE (expert opinion). Mayo Clinic, Rochester, Minn. April 28, 2010.
DS00769 July 10, 2010

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Advertisement


Text Size: smaller largerlarger